Bryostatin seen as treatment of Alzheimer's in addition to cancer

07/28/2004 | NYTimes.com

Researchers looking at bryostatin as a treatment for cancer now believe the drug also slows memory loss and helps prevent Alzheimer's disease. The drug has been approved by the FDA for cancer trials, but researchers are looking ahead to Alzheimer's trials after seeing bryostatin break down proteins responsible for amyloid plaques, the brain deposits associated with the disease.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX